I’m far from the first person to point out the prolonged market challenges that have depressed the biotech fundraising environment...
Read more
In the perpetual and never-ending race by the healthcare sector to unearth new approaches and therapeutics to address disease, one...
Read more
HotSpot’s trip to Barcelona for the recent European Society of Medical Oncology (ESMO) Annual Meeting was no ‘European Vacation,’ but...
Read more
As Boston’s weather has started its turn from the frigid darkness that is a northeast winter to the longer days...
Read more
Signaling pathways are the intricate networks that govern cell behavior, lying at the crux of cell function. They are used...
Read more
At HotSpot, we are committed to building something we believe is truly distinctive, setting ourselves apart from our peers in...
Read more
Every company has a culture, either by design or default. From our inception in 2016, we wanted to create a...
Read more
The phrase ‘build it and they will come’ dates all the way back to the Old Testament, and in more...
Read more
HotSpot Therapeutics recently announced FDA clearance of our Investigational New Drug (IND) application for HST-1011, our small molecule allosteric inhibitor...
Read more
White Hat Hackers, sometimes called “ethical hackers,” are individuals that work to find and fix security problems in a system...
Read more